VARIATIONS IN EFFECTIVENESS AND SAFETY OF GLECAPREVIR/PIBRENTASVIR AMONG HEPATITIS C PATIENTS WITH DIFFERENT GENOTYPES: A MULTI-INSTITUTIONAL COHORT STUDY IN TAIWAN
5PSQ-197
CONTRAINDICATED DRUG-DRUG INTERACTIONS WITH PAN-GENOTYPIC DIRECT ACTING ANTIVIRAL AGENTS IN CHRONIC HEPATITIS C PATIENTS IN TAIWAN
5PSQ-196
ASSOCIATION BETWEEN PHOSPHODIESTERASE 5 INHIBITOR USE AND INCIDENT DEMENTIA IN PROSTATE CANCER PATIENTS TREATED WITH ANDROGEN DEPRIVATION THERAPY
5PSQ-195
IMPACT OF INTENSIFIED CLINICAL DECISION SUPPORT SYSTEMS ON PRESCRIBING ERRORS: AN INTERRUPTED TIME SERIES ANALYSIS IN TAIWAN
5PSQ-194
MANAGEMENT OF EXPERIMENTAL HEALTH PRODUCTS IN HOSPITAL PHARMACIES: A NATIONAL SURVEY
5PSQ-193
PATIENT SAFETY IN MEDICATION DISPENSING PERFORMED BY PHARMACONOMISTS: A BEFORE AND AFTER STUDY
5PSQ-192
MEDICATION REVIEW OF POLYMEDICATED PATIENTS IN A HEALTH MANAGEMENT AREA
5PSQ-191
NEW GENERAL DRUG CHART, POST-IMPLEMENTATION CLINICAL AUDIT
5PSQ-190
EXPERIENCE AND SATISFACTION OF OUTPATIENTS IN THE DEVELOPMENT OF A PROGRAMME FOR HOME MEDICATION DELIVERY
5PSQ-189
NEAR MISS LOOKALIKE AND SOUNDALIKE INTRAVENOUS MEDICATION ERROR: A 12 MONTH RETROSPECTIVE STUDY
5PSQ-188
AN AUDIT OF PRESCRIBING, ADMINISTRATION AND STORAGE OF CONCENTRATED ELECTROLYTES
5PSQ-187
ALTERNATIVE TREATMENT TO ORAL IVERMECTIN IN STRONGYLOIDES STERCORALIS HYPERINFECTION IN THE SETTING OF SMALL BOWEL OBSTRUCTION AND PARALYTIC ILEUS
5PSQ-186
MAIN POTENTIAL INTERACTIONS DETECTED IN THE OUTPATIENT CONSULTATION
5PSQ-185
ARE ADHERENCE TESTS IN ASTHMA STILL RELIABLE WHEN THE PATIENTS KNOWS WHAT WE WANT TO HEAR?
5PSQ-184
KNOWLEDGE AND ATTITUDE ASSESSMENT OF PHARMACISTS TOWARD TELEPHARMACY IN RIYADH CITY, SAUDI ARABIA
